NEKTAR THERAPEUTICS Insider Trading for October 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEKTAR THERAPEUTICS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NEKTAR THERAPEUTICS for October 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 0 | |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,334 | 240,338 | 33,333 | |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Option Exercise | M | 7.21 | 33,333 | 240,331 | 66,667 | |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.68 | 33,333 | 589,327 | 312,775 | 346.1 K to 312.8 K (-9.63 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 346,108 | 312.8 K to 346.1 K (+10.66 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.48 | 33,334 | 582,678 | 312,775 | 346.1 K to 312.8 K (-9.63 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,334 | 240,338 | 346,109 | 312.8 K to 346.1 K (+10.66 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 17.17 | 24,500 | 420,665 | 312,775 | 337.3 K to 312.8 K (-7.26 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Sell | S | 16.35 | 8,833 | 144,420 | 337,275 | 346.1 K to 337.3 K (-2.55 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | ROBIN HOWARD W | President & CEO | Buy | M | 7.21 | 33,333 | 240,331 | 346,108 | 312.8 K to 346.1 K (+10.66 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 7.21 | 25,000 | 180,250 | 25,000 | |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 15.83 | 25,000 | 395,750 | 227,872 | 252.9 K to 227.9 K (-9.89 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 7.21 | 25,000 | 180,250 | 252,872 | 227.9 K to 252.9 K (+10.97 %) |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Lingnau Lutz | Director | Sell | S | 17.84 | 3,000 | 53,520 | 26,700 | 29.7 K to 26.7 K (-10.10 %) |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Zalevsky Jonathan | Chief R&D Officer | Grant | A | 0.00 | 75,000 | 0 | 295,657 | 220.7 K to 295.7 K (+33.99 %) |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 75,000 | 0 | 227,872 | 152.9 K to 227.9 K (+49.06 %) |
| Oct 01 2019 | NKTR | NEKTAR THERAPEUTIC ... | Ajer Jeffrey Robert | Director | Sell | S | 18.06 | 2,375 | 42,893 | 22,375 | 24.8 K to 22.4 K (-9.60 %) |
| Oct 01 2019 | NKTR | NEKTAR THERAPEUTIC ... | CHESS ROBERT | Director | Sell | S | 17.99 | 4,000 | 71,960 | 276,973 | 281 K to 277 K (-1.42 %) |